Apremilast-d5
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Apremilast-d5 Product Information
Apremilast-d5 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Apremilast. The product is supplied by Clearsynth under CAT No. CS-T-48307.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Apremilast-d5
CAS No.
1258597-47-5
CAT No.
CS-T-48307
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C₂₂H₁₉D₅N₂O₇S
Molecular Weight
465.53
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Apremilast-d5 is supplied with detailed characterization data compliant with regulatory guideline. Apremilast-d5 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Apremilast.
Overview
"Isotope labelled Apremilast , an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis. ;Labeled Apremilast, intended for use as an internal standard for the quantification of Apremilast by GC- or LC-mass spectrometry."
Synonyms
Apremilast-d5
Application Notes
"Isotope labelled Apremilast , an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis. ;Labeled Apremilast, intended for use as an internal standard for the quantification of Apremilast by GC- or LC-mass spectrometry."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.